Zacks Investment Research on MSN2d
Exelixis Stock Rises 13.3% Year to Date: Buy, Sell or Hold?Shares of Exelixis, Inc. EXEL have risen 13.3% year to date compared with the industry’s growth of 6.6%. The stock has also ...
In June 2024, Jiangsu Alphamab entered into a research and collaboration agreement with ArriVent BioPharma, Inc. to use Jiangsu Alphamab's proprietary linker-payload (Alphatecan) and glycan-specific ...
Scientists at Charles University and Mayo Foundation for Medical Education and Research (MFMER) have synthesized DNA topoisomerase II β inhibitors reported to be useful for the treatment of ...
In LAURA Phase III trial, TAGRISSO continues to demonstrate improved overall survival trend in unresectable, Stage III setting SAVANNAH and ORCHARD Phase II trials show the addition of savolitinib ...
UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States Department of Computational and Systems Biology, University of Pittsburgh, 3420 ...
The dichloromethane extract prepared from the underground parts of Eleutherine bulbosa (Miller) Urban (Iridaceae) showed strong activity in the direct bioautography assay with the phytopathogenic ...
A once renowned hero turns into a violent tyrant, and an empire falls into decline. A Liberation Army is rising up in an act of rebellion against an oppressive rule. One by one the 108 stars of ...
Panasonic has rung the changes on this second edition of its full-frame flagship. The Lumix S1R II improves upon the original S1R in every key area, battery life excepted. For me, the most ...
However, the exact functions of PLK1 in prophase remain incompletely understood. Here, we show that PLK1 inhibition in synchronous G2 cell populations of multiple mammalian cell lines delays or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback